Pamela B Allen,Mary Jo Lechowicz
Pamela B Allen
Extranodal natural killer (NK)/T-cell lymphoma, nasal type, is a rare peripheral T-cell lymphoma associated with Epstein-Barr virus. It most often presents as limited-stage disease in patients of East Asian descent with a palatal deformity ...
Building an Infrastructure and Standard Methodology for Actively Engaging Patients in Advance Care Planning [0.03%]
构建主动参与患者晚期照护计划的基础设施和标准化方法
Karen Stepan,Lara Bashoura,Marina George et al.
Karen Stepan et al.
Purpose: With little to no infrastructure or standardized methodology in place to actively engage patients in advance care planning (ACP), The University of Texas MD Anderson Cancer Center set out to identify needed resou...
Pembrolizumab and Severe Hypertriglyceridemia Requiring Apheresis: An Immune-Related Adverse Event [0.03%]
帕博利珠单抗与重度高甘油三酯血症并需行血液灌注的免疫相关不良事件
Malvi Thakker,Kalimullah Quadri,Ankuri Desai et al.
Malvi Thakker et al.
Kamal Kant Sahu,Ajay Kumar Mishra,Amos Lal
Kamal Kant Sahu
Reducing Unwarranted Oncology Care Variation Across a Clinically Integrated Network: A Collaborative Physician Engagement Strategy [0.03%]
临床整合网络中减少不应有的肿瘤护理差异：一种协作的医生参与策略
Jon M Richards,Trever B Burgon,Diana Tamondong-Lachica et al.
Jon M Richards et al.
Purpose: Addressing unwarranted clinical variation in oncology is a high priority for health systems that aspire to ensure consistent levels of high-quality and cost-effective care. Efforts to improve clinical practice an...
Optimizing the Care of Malignant Bowel Obstruction in Patients With Advanced Gynecologic Cancer [0.03%]
妇科 advanced gynecologic 癌症患者恶性肠梗阻的护理优化策略
Yeh Chen Lee,Nazlin Jivraj,Lisa Wang et al.
Yeh Chen Lee et al.
Purpose: Malignant bowel obstruction (MBO) is a common and distressing complication in women with advanced gynecologic cancer. A pilot, interprofessional MBO program was launched in 2016 at a large Canadian tertiary cance...
Shlomo A Koyfman,Nofisat Ismaila,F Christopher Holsinger
Shlomo A Koyfman
Are National Comprehensive Cancer Network Evidence Block Affordability Ratings Representative of Real-World Costs? An Evaluation of Advanced Non-Small-Cell Lung Cancer [0.03%]
美国国立综合癌症网络的证据块费率能否反映真实世界的花费？一项关于晚期非小细胞肺癌的评估研究
Joshua T Cohen,Pei-Jung Lin,Daniel M Sheinson et al.
Joshua T Cohen et al.
Purpose: The National Comprehensive Cancer Network (NCCN) developed the Evidence Blocks framework to assess the value of oncology regimens. This study characterizes the relationship between real-world costs and NCCN affor...
Clare Schilling,Stephen Y Lai,Soudeh Chegini et al.
Clare Schilling et al.
Personalized Medicine, Genomic Profiling and Germline Mutations: Toward More Precise Decisions [0.03%]
个性化医疗、基因组检测和胚系突变检测：迈向更精准的医疗决策
Ahmad Awada,Nagi S El Saghir
Ahmad Awada